Summit X, LLC Bristol Myers Squibb CO Transaction History

Summit X, LLC

$423 Million
Q3 2024

A detailed history of Summit X, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Summit X, LLC holds 40,470 shares of BMY stock, worth $2.34 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

40,470

Previous 41,003 1.3%

Holding current value

$2.34 Million

Previous $1.7 Million 23.03%

% of portfolio

0.5%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$39.66 - $51.75 $21,138 - $27,582	-533 Reduced 1.3%	40,470 $2.09 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $135,441 - $178,311	3,365 Added 8.94%	41,003 $1.7 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $1.81 Million - $2.05 Million	37,638 New	37,638 $2.04 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $268,954 - $313,537	-5,015 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $364,546 - $427,018	-6,161 Reduced 55.13%	5,015 $303,000
Q2 2021 Jul 16, 2021	SELL	$61.91 - $67.42 $12,691 - $13,821	-205 Reduced 1.8%	11,176 $745,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $59,280 - $66,673	-999 Reduced 8.07%	11,381 $724,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $61,088 - $69,224	1,058 Added 9.34%	12,380 $767,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $5,857 - $6,491	102 Added 0.91%	11,322 $7.66 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $615,080 - $719,089	11,220 New	11,220 $660,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $164,223 - $212,958	-3,368 Closed	0 $0
Q3 2018 Nov 01, 2018	SELL	$55.19 - $62.25 $65,952 - $74,388	-1,195 Reduced 26.19%	3,368 $209,000
Q2 2018 Sep 24, 2018	BUY	$50.53 - $62.98 $161,089 - $200,780	3,188 Added 231.85%	4,563 $252,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $195,348 - $243,480	-3,866 Reduced 73.76%	1,375 $252,000
Q1 2018 May 23, 2018	BUY	$59.92 - $68.98 $62,017 - $71,394	1,035 Added 24.61%	5,241 $330,000
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $46,273 - $50,450	772 Added 22.48%	4,206 $259,000
Q3 2017 Oct 17, 2017	SELL	$55.23 - $63.74 $260,078 - $300,151	-4,709 Reduced 57.83%	3,434 $217,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,143	8,143 $454,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account